A new technique inducing mitral valve regurgitation as an experimental porcine model of volume-overload induced heart failure

S Sven L. Van Laer B Bo Goovaerts S Steven Laga M Michiel R. L. Tubeeckx S Siel Van den Bogaert H Hein Heidbüchel (University Hospital Antwerp, Antwerp, Belgium) V Vincent F. M. Segers M Marc J. Claeys

Abstract

Abstract Heart failure (HF) is a common disease resulting in high morbidity, mortality, and healthcare costs. An important cause of HF is mitral valve regurgitation (MR), which induces left ventricular remodeling and volume overload. For HF research, a reproducible and reliable large animal model is crucial. Several MR models have been developed, but they often show high variability in MR severity and MR jet characteristics, as well as an underlying ischemic cardiomyopathy, which may increase the risk of complications during follow-up. We present a straightforward and uniform porcine model of primary MR-induced HF. A custom-made retractor was used to induce severe and uniform MR by chordal rupture. After four weeks, severe MR led to significant left ventricular remodeling compared to the sham group, with a significant increase in left ventricular end-diastolic (+34.5 ± 6.8 ml vs. +8.4 ± 5.3 ml, p  = 0.023) and end-systolic volume (+29.9 ± 4.0 ml vs. +4.2 ± 2.9 ml, p  = 0.001), a decrease in left ventricular ejection fraction (-11.9 ± 1.9% vs. -0.7 ± 0.9%, p  < 0.001) and fractional shortening (-12.2 ± 1.3% vs. -2.2 ± 0.8%, p  < 0.001), and a higher amount of left ventricular fibrosis (12.6 ± 1.0% vs. 6.4 ± 0.9%, p  = 0.001). This porcine model allows a straightforward and reproducible induction of primary MR-induced HF, with a high success rate. It could be valuable in basic research to study the underlying pathophysiology and in translational research to develop novel diagnostics and therapeutics targeting volume-overload induced HF and/or primary MR.

Article Details

Volume / Issue Vol. 16, Issue 1
Published March 14, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (8)

S

Sven L. Van Laer

B

Bo Goovaerts

S

Steven Laga

M

Michiel R. L. Tubeeckx

S

Siel Van den Bogaert

H

Hein Heidbüchel

University Hospital Antwerp, Antwerp, Belgium

V

Vincent F. M. Segers

M

Marc J. Claeys